| This article has been cited by |
| 1 | When to Avoid a Restaging Procedure for Non-muscle Invasive Bladder Cancer? Inferences from a Tertiary Care Center | |
| Deepak Prakash Bhirud,Ankur Mittal,Sunil Kumar,Tushar Aditya Narain,Sanjeev Kishore,Shiv Charan Navriya,Satish Kumar Ranjan,Vikas Kumar Panwar |
| Indian Journal of Surgical Oncology.2022;13(3)604 |
| [DOI] |
|
| 2 | Urinary Extracellular Vesicles as Potential Biomarkers for Urologic Cancers: An Overview of Current Methods and Advances | |
| Catarina Lourenço,Vera Constâncio,Rui Henrique,Ângela Carvalho,Carmen Jerónimo |
| Cancers.2021;13(7)1529 |
| [DOI] |
|
| 3 | The Urinary Microbiome and Bladder Cancer: Susceptibility and Immune Responsiveness | |
| Ciro Andolfi,Jeffrey C. Bloodworth,Apostolos Papachristos,Randy F. Sweis |
| Bladder Cancer.2020;6(3)225 |
| [DOI] |
|
| 4 | Spinal Tuberculosis Secondary to Intravesical Bacille Calmette-Guerin Treatment for Bladder Cancer | |
| Celeste G Yergin,Ryan Pafford,John Pirris,Dinesh Rao,Gazanfar Rahmathulla |
| Cureus.2021;6(3)225 |
| [DOI] |
|
| 5 | How to Perform Intravesical Chemotherapy after Second TURBT for Non-Muscle-Invasive Bladder Cancer: A Single-Center Experience | |
| Zhen Li,Nienie Qi,Zhimin Gao,Li Ding,Jiawei Zhu,Qingxiang Guo,Junqi Wang,Rumin Wen,Hailong Li |
| Journal of Clinical Medicine.2022;12(1)169 |
| [DOI] |
|
| 6 | Does post-void residual urine volume affect potential recurrence risk for non-muscle invasive bladder cancer? | |
| Mohammad Talal Al-Zubi,Saddam Al Demour,Samer Fathi Al-Rawashdah,Antonio Carbone,Antonio Luigi Pastore,Mohannad Abuhamad,Saleh Abuorouq,Rami Al-Azab,Morad Bani-Hani,Mohammad Al-Qudah,Basel Elayan |
| Future Science OA.2022;8(9)169 |
| [DOI] |
|
| 7 | Unmet needs in sexual health in bladder cancer patients: a systematic review of the evidence | |
| Agustina Bessa,Rebecca Martin,Christel Häggström,Deborah Enting,Suzanne Amery,Muhammad Shamim Khan,Fidelma Cahill,Harriet Wylie,Samantha Broadhead,Kathryn Chatterton,Sachin Malde,Rajesh Nair,Ramesh Thurairaja,Pardeep Kumar,Anna Haire,Saran Green,Margaret Northover,Karen Briggs,Mieke Van Hemelrijck |
| BMC Urology.2020;20(1)169 |
| [DOI] |
|
| 8 | Mycobacterium bovis bacille Calmette–Guerin-derived extracellular vesicles as an alternative to live BCG immunotherapy | |
| Patrick Gellings,Michelle Galeas-Pena,Lisa A. Morici |
| Clinical and Experimental Medicine.2022;20(1)169 |
| [DOI] |
|
| 9 | Development and external validation of a novel nomogram model for predicting postoperative recurrence-free survival in non-muscle-invasive bladder cancer | |
| Li Ding,Xiaobin Deng,Wentao Xia,Kun Wang,Yang Zhang,Yan Zhang,Xianfeng Shao,Junqi Wang |
| Frontiers in Immunology.2022;13(1)169 |
| [DOI] |
|
| 10 | BCG Therapy of Bladder Cancer Stimulates a Prolonged Release of the Chemoattractant CXCL10 (IP10) in Patient Urine | |
| Omodele Ashiru,Gloria Esteso,Eva M. García-Cuesta,Eva Castellano,Celia Samba,Eva Escudero-López,Sheila López-Cobo,Mario Álvarez-Maestro,Ana Linares,Mei M. Ho,Asier Leibar,Luis Martínez-Piñeiro,Mar Valés-Gómez |
| Cancers.2019;11(7)940 |
| [DOI] |
|
| 11 | Diabetes Mellitus and Obesity as Risk Factors for Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis | |
| Yu Lu,Jing Tao |
| Frontiers in Endocrinology.2021;12(7)940 |
| [DOI] |
|
| 12 | Synthesis and characterization of gold nanoparticles from Abies spectabilis extract and its anticancer activity on bladder cancer T24 cells | |
| Tao Wu,Xi Duan,Chunyan Hu,Changqiang Wu,Xiaobin Chen,Jing Huang,Junbo Liu,Shu Cui |
| Artificial Cells, Nanomedicine, and Biotechnology.2019;47(1)512 |
| [DOI] |
|
| 13 | Bladder cancer diagnosis with a four-miRNA panel in serum | |
| Xinji Li,Wenkang Chen,Rongkang Li,Xuan Chen,Guocheng Huang,Chong Lu,Zhenyu Wen,Xiqi Peng,Kaihao Liu,Chunduo Zhang,Hang Li,Yimin Hu,Zhengping Zhao,Lingzhi Tao,Yongqing Lai |
| Future Oncology.2022;18(29)3311 |
| [DOI] |
|
| 14 | Formulation and characterization of EGCG for the treatment of superficial bladder cancer | |
| Katarzyna Dettlaff,Maciej Stawny,Magdalena Ogrodowczyk,Anna Jelinska,Waldemar Bednarski,Dorota Watróbska-Swietlikowska,Rick W. Keck,Omar A. Khan,Ibrahim H. Mostafa,Jerzy Jankun |
| International Journal of Molecular Medicine.2017;40(2)329 |
| [DOI] |
|
| 15 | Development of a predictive model for recurrence-free survival in pTa low-grade bladder cancer | |
| Jorge Daza,Ralph Grauer,Sophie Chen,Etienne Lavallèe,Shirin Razdan,Linda Dey,Gunnar Steineck,Lotta Renström-Koskela,Qiang Li,Ahmed A. Hussein,Reza Mehrazin,Nikhil Waingankar,Khurshid Guru,Peter Wiklund,John P. Sfakianos |
| Urologic Oncology: Seminars and Original Investigations.2023;40(2)329 |
| [DOI] |
|
| 16 | A Way Forward for Cancer Chemoprevention: Think Local | |
| Luai Al Rabadi,Raymond Bergan |
| Cancer Prevention Research.2017;10(1)14 |
| [DOI] |
|
| 17 | Active surveillance for nonmuscle invasive bladder cancer | |
| Makito Miyake,Kiyohide Fujimoto,Yoshihiko Hirao |
| Investigative and Clinical Urology.2016;57(Suppl 1)S4 |
| [DOI] |
|
| 18 | Expression of L-Type Amino Acid Transporter 1 is a Predictive Biomarker of Intravesical Recurrence in Patients with Non-Muscle Invasive Bladder Cancer | |
| Harutake Sawazaki,Yuichi Arai,Yuji Ito,Kimiya Sato,Hitoshi Tsuda,Takashi Yamaga,Hiroyuki Sakurai |
| Research and Reports in Urology.2021;Volume 13(Suppl 1)603 |
| [DOI] |
|
| 19 | Bone morphogenic proteins-2, -4, -6 and 7 in non-muscle invasive bladder cancer | |
| Tvrtko Hudolin,Zeljko Kastelan,Ahmad El-Saleh,Mirko Bakula,Marijana Coric,Petar Kes,Davor Tomas,Nikolina Basic-Jukic |
| Oncology Letters.2019;Volume 13(Suppl 1)603 |
| [DOI] |
|
| 20 | Increased Bacillus Calmette-Guérin Treatment Intensity Associated With Improved Outcomes in Elderly Patients With Non–Muscle-invasive Bladder Cancer in United States Clinical Practice | |
| Kyle A. Richards,Shih-Wen Lin,Ching-Yi Chuo,Christina L. Derleth,Jingbo Yi,Marko Zivkovic,Sarika Ogale,Sandip Prasad,G. Joel Decastro,Gary D. Steinberg |
| Urology.2020;145(Suppl 1)172 |
| [DOI] |
|
| 21 | Non-Muscular Invasive Bladder Cancer: Re-envisioning Therapeutic Journey from Traditional to Regenerative Interventions | |
| Kuan-Wei Shih,Wei-Chieh Chen,Ching-Hsin Chang,Ting-En Tai,Jeng-Cheng Wu,Andy C. Huang,Ming-Che Liu |
| Aging and disease.2021;12(3)868 |
| [DOI] |
|
| 22 | Immune Checkpoint and Telomerase Crosstalk Is Mediated by miRNA-138 in Bladder Cancer | |
| Hajar El Ahanidi,Meryem El Azzouzi,Chaimae Hafidi Alaoui,Mohammed Tetou,Mounia Bensaid,Imane Chaoui,Laila Benbacer,Ilias Hassan,Mohamed Oukabli,Katarzyna Michaud,Ahmed Ameur,Abderrahmane Al Bouzidi,Mohammed El Mzibri,Camilla Jandus,Mohammed Attaleb |
| Frontiers in Oncology.2022;11(3)868 |
| [DOI] |
|
| 23 | Risk-Based Assessment Of the Impact Of Intravesical Therapy on Recurrence-Free Survival Rate Following Resection of Suspected Low-grade, Non-muscle-invasive Bladder Cancer (NMIBC): A Southwest Oncology Groups (SWOG) S0337 Posthoc Analysis | |
| Nicholas J. Corsi,Edward M. Messing,Akshay Sood,Jacob Keeley,Chandler Bronkema,Nikola Rakic,Marcus Jamil,Deepansh Dalela,Sohrab Arora,Austin J. Piontkowski,Sami E. Majdalany,Mohit Butaney,Ivan Rakic,Pin Li,Mani Menon,Craig G. Rogers,Firas Abdollah |
| Clinical Genitourinary Cancer.2022;20(6)e498 |
| [DOI] |
|
| 24 | Anti-Cancer Auto-Antibodies: Roles, Applications and Open Issues | |
| Hugo de Jonge,Luisa Iamele,Maristella Maggi,Greta Pessino,Claudia Scotti |
| Cancers.2021;13(4)813 |
| [DOI] |
|
| 25 | Preoperative Systemic Inflammatory Markers as a Significant Prognostic Factor After TURBT in Patients with Non-Muscle-Invasive Bladder Cancer | |
| Li Ding,Xiaobin Deng,Kun Wang,Wentao Xia,Yang Zhang,Yan Zhang,Xianfeng Shao,Junqi Wang |
| Journal of Inflammation Research.2023;Volume 16(4)283 |
| [DOI] |
|
| 26 | Detrimental Effect of Various Preparations of the Human Amniotic Membrane Homogenate on the 2D and 3D Bladder Cancer In vitro Models | |
| Aleksandar Janev,Taja Železnik Ramuta,Larisa Tratnjek,Žiga Sardoc,Hristina Obradovic,Slavko Mojsilovic,Milena Taskovska,Tomaž Smrkolj,Mateja Erdani Kreft |
| Frontiers in Bioengineering and Biotechnology.2021;9(4)283 |
| [DOI] |
|
| 27 | An insight into the diagnostic and prognostic value of
HOX A13
’s expression in non-muscle invasive bladder cancer | |
| Nouha Setti Boubaker,Aymone Gurtner,Nesrine Trabelsi,Isabella Manni,Ahlem Blel,Ahmed Saadi,Marouene Chakroun,Zeineb Naimi,Selim Zaghbib,Meriam Ksontini,Khedija Meddeb,Soumaya Rammeh,Haroun Ayed,Mohamed Chebil,Giulia Piaggio,Slah Ouerhani |
| Journal of Clinical Laboratory Analysis.2022;36(9)283 |
| [DOI] |
|
| 28 | Radical treatment of muscle-invasive bladder cancer—are options equal? | |
| David Fackrell,Andrea Marshall,Pankaj Mistry,Janet Dunn,Maria De Santis,Daniel Ford,Anjali Zarkar |
| Journal of Radiation Oncology.2018;7(2)181 |
| [DOI] |
|
| 29 | Cancer-Associated Membrane Protein as Targeted Therapy for Bladder Cancer | |
| Adlina Roslan,Nurshahira Sulaiman,Khairul Asri Mohd Ghani,Armania Nurdin |
| Pharmaceutics.2022;14(10)2218 |
| [DOI] |
|
| 30 | Prediction of Bladder Cancer Treatment Side Effects Using an Ontology-Based Reasoning for Enhanced Patient Health Safety | |
| Chamseddine Barki,Hanene Boussi Rahmouni,Salam Labidi |
| Informatics.2021;8(3)55 |
| [DOI] |
|
| 31 | Preoperative systemic immune-inflammation index as a significant prognostic factor after
TURBT
in patients with non-muscle-invasive bladder cancer: A retrospective study based on propensity score matching analysis | |
| Li Ding,Xiangbu Wang,Xiaobin Deng,Wentao Xia,Kun Wang,Xianlin Yu,Yaotian Huang,Junqi Wang |
| Cancer Medicine.2022;8(3)55 |
| [DOI] |
|
| 32 | The role of neutrophil to lymphocyte ratio in patients with pTa non-muscle invasive bladder cancer | |
| Orsolya Mártha,Daniel Balan,Daniel Porav-Hodade,Emoke Drágus,Mihai Dorin Vartolomei,Calin Bogdan Chibelean,Angela Borda,Ákos Pytel,Olivér Árpád Vida |
| Revista Romana de Medicina de Laborator.2020;28(1)29 |
| [DOI] |
|
| 33 | Non-muscle invasive bladder cancer tissues have increased base excision repair capacity | |
| Berna Somuncu,Selcuk Keskin,Fatma Merve Antmen,Yesim Saglican,Aysegul Ekmekcioglu,Tugce Ertuzun,Mustafa Bilal Tuna,Can Obek,David M. Wilson,Umit Ince,Ali Riza Kural,Meltem Muftuoglu |
| Scientific Reports.2020;10(1)29 |
| [DOI] |
|
| 34 | Validation of grading of non-invasive urothelial carcinoma by digital pathology for routine diagnosis | |
| Richard Colling,Hayleigh Colling,Lisa Browning,Clare Verrill |
| BMC Cancer.2021;21(1)29 |
| [DOI] |
|
| 35 | Physical activity patterns and associations with health-related quality of life in bladder cancer survivors | |
| Ajay Gopalakrishna,Thomas A. Longo,Joseph J. Fantony,Michael R. Harrison,Brant A. Inman |
| Urologic Oncology: Seminars and Original Investigations.2017;35(9)540.e1 |
| [DOI] |
|
| 36 | Microbiome in Bladder Cancer: A Systematic Review | |
| Yong-Nam Gwon,Jae-Joon Park,Ki-Soo Lee,Kong-Hee Lee,Tae-Hyo Kim,Jae-Heon Kim |
| Diagnostics.2022;13(1)84 |
| [DOI] |
|
| 37 | Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer | |
| Mahmoud Ganji,Shohreh Bakhshi,Alireza Shoari,Reza Ahangari Cohan |
| Journal of Translational Medicine.2023;21(1)84 |
| [DOI] |
|
| 38 | Anticancer Effects of Gold Nanoparticles by Inducing Apoptosis in Bladder Cancer 5637 Cells | |
| Sajedeh Daei,Nasrin Ziamajidi,Roghayeh Abbasalipourkabir,Korosh Khanaki,Fatemeh Bahreini |
| Biological Trace Element Research.2022;200(6)2673 |
| [DOI] |
|
| 39 | Prognostic value of HER-2/neu, Ki-67, MCM-2, and p21 expression in nonmuscle invasive bladder cancer | |
| Eman N. Khorshid,Mervat M.F. El Deftar,Ghada S. Osman |
| Egyptian Journal of Pathology.2017;37(2)352 |
| [DOI] |
|
| 40 | Prognostic value of HER-2/neu, Ki-67, MCM-2, and p21 expression in nonmuscle invasive bladder cancer | |
| Sanchia S. Goonewardene,Raj Persad,Hanif Motiwala,David Albala |
| Egyptian Journal of Pathology.2020;37(2)123 |
| [DOI] |
|
| 41 | The Impact of Physical Activity on Risk and Health-Related Quality of Life in Bladder Cancer | |
| Marina Rodríguez Cintas,Sara Márquez,Javier González-Gallego |
| Bladder Cancer.2021;7(3)355 |
| [DOI] |
|
